Do Phase 1 trials use a placebo? What the words on a listing usually mean

When a Phase 1 trial listing or consent form mentions "placebo," "comparator" or "open-label," it helps to know what those words usually mean. The short answer to "do Phase 1 trials use a placebo?" is: sometimes, but that is not the default most people imagine.

What Phase 1 is built to learn. FDA describes Phase 1 as safety-and-dosage work in a relatively small group, often about 20 to 100 people. For cancer drugs, Phase 1 studies are generally done in people who have that cancer. NCI's patient pages put many cancer Phase 1 studies at roughly 15 to 30 people. The goal is to learn about safety, side effects and a tolerable dose, not to prove a new treatment beats standard care. Later phases ask those questions.

What "placebo" means. NCI defines a placebo as an inactive substance or other intervention that looks the same as, and is given the same way as, the active treatment being tested. A control group is the group that does not receive the new treatment. A control can be a placebo, an accepted standard therapy, or another comparator named in the protocol, so the two words are related but not identical.

Are placebos common in cancer trials? NCI says placebos are rarely used in cancer treatment clinical trials. Most comparative studies give one group the new treatment and another an already approved standard treatment. NIH adds that placebos are not used if you would be put at risk by not having effective therapy. When a cancer study does use one, NCI says you are told ahead of time and the consent form covers it. Two patterns NCI lists: when no standard treatment exists, or when the trial compares standard treatment plus placebo with standard treatment plus the study treatment, in which case everyone still gets accepted care.

Designs you may see instead. Many Phase 1 studies raise the dose a little at a time (a dose-escalation study) to find the highest dose that does not cause harmful side effects. Some are open-label, meaning both providers and participants know which treatment is being given.

How to check one study. Open its ClinicalTrials.gov record (the page with the NCT number). Look at the interventions and the arm or group descriptions: if a placebo is used, the intervention list often says "Placebo." Also check the allocation and masking fields, if filled in. None of this replaces the consent form and the conversation with the study team.

Questions to ask the study team or your clinician:

• Does this study use a placebo, a standard-care comparator, both, or neither?

• If there is a placebo, does everyone still get accepted care?

• Will I know what I am receiving, or is the study blinded?

The full explainer, with the FDA, NCI and NIH sources listed, is at Triangle Health: https://www.trianglehealth.com/answers/does-a-phase-1-trial-use-a-placebo

Educational only, not medical advice. Please discuss clinical trial decisions with your clinician and the study team.